ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 140701 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 140701; 2) Community: the network communities that were significantly associated with the response to NSC 140701; 3) Molecule: the relationships between components within communities and NSC 140701; 4) MDR: the compounds that were significantly associated with the NSC 140701.

NSC Compound Enrichment Correlation
NSC 176323 Camptothecin Derivative 0.0105972823829604 0.67229009
NSC 330507 Tanespimycin 0.0105972823829604 0.19394286
NSC 346098 Null 0.0105972823829604 0.05211663
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0105972823829604 0.055846068
NSC 629971 Camptothecin Derivative 0.0105972823829604 0.73742632
NSC 645018 1,4-bis(N-Cysteinyldiethylamino)-5,8-dihydroxy anthraquinon 0.0105972823829604 0.810762
NSC 660841 Null 0.0105972823829604 0.21031995
NSC 70931 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- 0.0105972823829604 -0.12932232
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.0105972823829604 0.13761733
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.0105972823829604 0.0667068
Total:66  Current:14    [First] [Prev] [Next] [Last]